1. Development of Boron-Cluster-Based Progesterone Receptor Antagonists Bearing a Pentafluorosulfanyl (SF5) Group
- Author
-
Shinya Fujii, Hiroyuki Kagechika, Tomoya Kasagawa, Nozomi Tsuemoto, Eiichi Nakano, and Shuichi Mori
- Subjects
010405 organic chemistry ,Chemistry ,Stereochemistry ,Antagonist ,General Chemistry ,General Medicine ,010402 general chemistry ,01 natural sciences ,0104 chemical sciences ,chemistry.chemical_compound ,Drug Discovery ,Progesterone receptor ,Functional group ,Carborane ,Pharmacophore ,Function (biology) ,Binding domain ,Cluster based - Abstract
The progesterone receptor (PR) plays an important role in various physiological processes, especially in the female reproductive system, and abnormalities of PR function are associated with several diseases, including some types of cancer. Non-steroidal PR ligands are of interest as candidate drugs for treatment of PR-related diseases without the serious adverse effects that may be caused by steroidal ligands. For the development of non-steroidal PR ligands, both a hydrophobic backbone and a polar functional group corresponding to the 3-carbonyl group of progesterone, which interacts with Gln725 and Arg766 of the PR-ligand binding domain, are critically important. We previously showed that carborane is a useful hydrophobic pharmacophore for PR antagonists, and in this work, we introduced the pentafluorosulfanyl (SF5) group as a novel polar functional group of carborane-based non-steroidal PR antagonists. All the synthesized SF5-containing carborane derivatives exhibited PR-antagonistic activity at micromolar or submicromolar concentration. Among them, compounds 11 are potent progesterone antagonists with submicromolar IC50 values.
- Published
- 2019
- Full Text
- View/download PDF